Contact Information
Company Information
Company
Ensem Therapeutics
Professional Summary
Shengfang Jin serves as President and CEO at Ensem Therapeutics. Ensem Therapeutics operates in the biotechnology sector with approximately 25.0 employees. The company is headquartered in Boston, Massachusetts. Ensem Therapeutics generates annual revenue of 1300000.0. To date, Ensem Therapeutics has raised 67000000.0 in total funding, with the most recent round being Series A.
Industry & Role Insights
-
•
MessageCEO tracks 381 executives in the biotechnology sector.
-
•
3,781 executive contacts are available in Massachusetts.
-
•
Our database includes 201,468 c suite-level executives.
Technologies
Outlook
GoDaddy Hosting
Mobile Friendly
WordPress.org
Vimeo
Varnish
Remote
AI
Keywords
precision medicine
small molecule drugs
cryptic binding pockets
structure-based drug design
oncology
ai deep learning
computational methodologies
drug discovery
kinetic ensemble platform
high-value targets
difficult-to-drug targets
binding pocket prediction
ligand design
kinetic ensemble technology
biophysical technologies
pharmacokinetic modeling
drug metabolism & pharmacokinetics
dmpk
clinical trial phases
phase i clinical trials
bioavailability
experimental techniques
metastable states
de novo drug design
synthetic optimization
protein dynamics
computational chemistry
translational research
cancer therapies
epigenetic therapies
clinical-stage drug development
biomedical research
drug candidates
preclinical research
scalable technologies
targeted oncology
drug design strategies
novel therapeutic targets
molecular dynamics simulations
therapeutic innovation
multi-target strategy
high-throughput screening
hybrid modeling
intelligent algorithms
drug efficacy
research & development
therapeutic intervention
biotechnology innovation
protein-ligand interactions
hospital & health care
Related Executives
Outreach Guidance — biotechnology Sector
Technology executives make decisions on infrastructure, tooling, and partnerships. When reaching out to Shengfang Jin, lead with your value proposition relative to the stack they currently use. Generic pitches perform poorly; specific technical relevance is key.
Shengfang Jin's Position in the MessageCEO Database
- •Shengfang Jin is 1 of 1 verified executive contact we track at Ensem Therapeutics.
- •365 verified executive contacts in biotechnology are in the MessageCEO database.
- •3,577 verified executive contacts in Massachusetts are in the database.
- •11 verified contacts work at biotechnology companies in the 25.0 employee range (same size as Ensem Therapeutics).
Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated July 2026.
Frequently Asked Questions
How do I reach Shengfang Jin directly?
Shengfang Jin's verified email address is available to MessageCEO Pro subscribers. They currently serve as President and CEO at Ensem Therapeutics. Access direct contact info to skip gatekeepers and reach the decision maker.
What company does Shengfang Jin work for?
Shengfang Jin is President and CEO at Ensem Therapeutics, a company in the biotechnology sector with 25.0 employees. The company is based in Boston, Massachusetts.
Can I pitch or sell to Shengfang Jin?
As President and CEO at Ensem Therapeutics, Shengfang Jin is a key decision-maker in the biotechnology sector. MessageCEO Pro gives you verified email to reach Shengfang Jin directly — ideal for B2B sales, partnerships, and executive recruiting.
What industry is Shengfang Jin in?
Shengfang Jin works in the biotechnology industry as President and CEO at Ensem Therapeutics. MessageCEO provides verified contact information for executives across all major industries.
Is Shengfang Jin's contact information verified?
Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Shengfang Jin's profile is kept up-to-date with the latest available information.
Last updated: July 27, 2026
Get Full Contact Details
Subscribe to reveal email addresses and export contacts.
View Plans